LINC01133 and neoplasm: LINC01133 overexpression and silencing assays in the CNE-1 and SUNE-1 human tumor cell lines, respectively, showed that increasing LINC01133 expression negatively modulated Snail and N-cadherin expression, leading to increased E-cadherin expression and decreased EMT processes, while a switch occurred upon LINC01133 silencing [96].